Global and Japan Lung Cancer Liquid Biopsy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Lung Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 CTCs
  • 1.2.3 CtDNA
  • 1.2.4 Exosomes And RNA
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Lung Cancer Liquid Biopsy Market Share by Application: 2020 VS 2026
  • 1.3.2 Clinics
  • 1.3.3 Hospitals
  • 1.3.4 Physicians' Office Laboratories
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Lung Cancer Liquid Biopsy Market Perspective (2015-2026)
• 2.2 Global Lung Cancer Liquid Biopsy Growth Trends by Regions
  • 2.2.1 Lung Cancer Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Lung Cancer Liquid Biopsy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Lung Cancer Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Lung Cancer Liquid Biopsy Players by Market Size
  • 3.1.1 Global Top Lung Cancer Liquid Biopsy Players by Revenue (2015-2020)
  • 3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2015-2020)
• 3.2 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Lung Cancer Liquid Biopsy Revenue
• 3.4 Global Lung Cancer Liquid Biopsy Market Concentration Ratio
  • 3.4.1 Global Lung Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biopsy Revenue in 2019
• 3.5 Key Players Lung Cancer Liquid Biopsy Area Served
• 3.6 Key Players Lung Cancer Liquid Biopsy Product Solution and Service
• 3.7 Date of Enter into Lung Cancer Liquid Biopsy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biopsy Breakdown Data by Type (2015-2026)

• 4.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2015-2020)
• 4.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2021-2026)

5 Lung Cancer Liquid Biopsy Breakdown Data by Application (2015-2026)

• 5.1 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2015-2020)
• 5.2 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Lung Cancer Liquid Biopsy Market Size (2015-2026)
• 6.2 North America Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 6.3 North America Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
• 6.4 North America Lung Cancer Liquid Biopsy Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Lung Cancer Liquid Biopsy Market Size (2015-2026)
• 7.2 Europe Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 7.3 Europe Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
• 7.4 Europe Lung Cancer Liquid Biopsy Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Lung Cancer Liquid Biopsy Market Size (2015-2026)
• 8.2 China Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 8.3 China Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
• 8.4 China Lung Cancer Liquid Biopsy Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Lung Cancer Liquid Biopsy Market Size (2015-2026)
• 9.2 Japan Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 9.3 Japan Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
• 9.4 Japan Lung Cancer Liquid Biopsy Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Lung Cancer Liquid Biopsy Market Size (2015-2026)
• 10.2 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Type (2015-2020)
• 10.3 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Application (2015-2020)
• 10.4 Southeast Asia Lung Cancer Liquid Biopsy Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Biocept
  • 11.1.1 Biocept Company Details
  • 11.1.2 Biocept Business Overview
  • 11.1.3 Biocept Lung Cancer Liquid Biopsy Introduction
  • 11.1.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2015-2020))
  • 11.1.5 Biocept Recent Development
• 11.2 Exosome Diagnostics
  • 11.2.1 Exosome Diagnostics Company Details
  • 11.2.2 Exosome Diagnostics Business Overview
  • 11.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Introduction
  • 11.2.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
  • 11.2.5 Exosome Diagnostics Recent Development
• 11.3 F. Hoffmann-La Roche
  • 11.3.1 F. Hoffmann-La Roche Company Details
  • 11.3.2 F. Hoffmann-La Roche Business Overview
  • 11.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Introduction
  • 11.3.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
  • 11.3.5 F. Hoffmann-La Roche Recent Development
• 11.4 Qiagen
  • 11.4.1 Qiagen Company Details
  • 11.4.2 Qiagen Business Overview
  • 11.4.3 Qiagen Lung Cancer Liquid Biopsy Introduction
  • 11.4.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
  • 11.4.5 Qiagen Recent Development
• 11.5 Accuragen
  • 11.5.1 Accuragen Company Details
  • 11.5.2 Accuragen Business Overview
  • 11.5.3 Accuragen Lung Cancer Liquid Biopsy Introduction
  • 11.5.4 Accuragen Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
  • 11.5.5 Accuragen Recent Development
• 11.6 Agena Bioscience
  • 11.6.1 Agena Bioscience Company Details
  • 11.6.2 Agena Bioscience Business Overview
  • 11.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Introduction
  • 11.6.4 Agena Bioscience Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
  • 11.6.5 Agena Bioscience Recent Development
• 11.7 Bard1
  • 11.7.1 Bard1 Company Details
  • 11.7.2 Bard1 Business Overview
  • 11.7.3 Bard1 Lung Cancer Liquid Biopsy Introduction
  • 11.7.4 Bard1 Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
  • 11.7.5 Bard1 Recent Development
• 11.8 Bgi
  • 11.8.1 Bgi Company Details
  • 11.8.2 Bgi Business Overview
  • 11.8.3 Bgi Lung Cancer Liquid Biopsy Introduction
  • 11.8.4 Bgi Revenue in Lung Cancer Liquid Biopsy Business (2015-2020)
  • 11.8.5 Bgi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer